These subtypes are highly expressed in gene markers featured in highly invasive and aggressive breast cancer phenotypes such as VIM, MMP2/14, COL3A1, CD24(-), and CD44(+).Classification based on gene expression profile is still developing [22,23], which makes characterization of breast cancer even more complex. This evidence concerns the gene MMP2 and breast cancer.